PDF (813K)
摘要
目的 分析复发性流产(RSA)患者抗磷脂抗体(aPL)分布特征及妊娠结局。方法 收集 2020 年 1 月至 2024 年 12 月在大连医科大学附属第一医院住院治疗的 RSA 患者 167 例,根据 aPL 检测结果分为 aPL 阳性组 68 例和 aPL 阴性组 99 例,根据两组中是否接受小剂量阿司匹林(LDA)和(或)低分子肝素(LMWH)治疗进一步分为治疗组与未治疗组,并比较各组的妊娠结局。结果 167 例 RSA 患者中 aPL 阳性率 40.72%,其中狼疮抗凝物(LA)、抗心磷脂抗体(aCL)、抗 β2 糖蛋白 1 抗体(anti-β2-GP1)阳性率分别为 24.55%、4.19%、1.80%;任意两个抗体同时阳性者占比 7.78%;三个抗体均阳性者占比 2.40%。aPL 阳性与阴性组中接受治疗的孕妇子痫前期的发生率均明显小于未治疗者(P<0.05);aPL 阳性组中,治疗组的妊娠至足月分娩率、新生儿出生体重明显高于未治疗组(P<0.01);且胎儿生长受限(FGR)、早产的发生率也明显低于未治疗组(P<0.05)。aPL 阴性组中,治疗组的早产率明显低于未治疗组、新生儿出生体重明显高于未治疗组(P<0.05)。结论 aPL 与 RSA 密切相关,针对 RSA 患者应积极筛查 aPL,对抗体阳性者给予 LDA 和(或)LMWH 治疗;对抗体阴性者,在充分告知前提下,进行个体化治疗,有望获得满意妊娠结局。
Abstract
Objective To analyze the distribution characteristics of antiphospholipid antibodies (aPL) and pregnancy outcomes in patients with recurrent spontaneous abortion (RSA). Methods A total of 167 patients with RSA who were hospitalized at the First Affiliated Hospital of Dalian Medical University from January 2020 to December 2024 were enrolled in the study. Based on aPL test results, patients were divided into an aPL-positive group (68 cases) and an aPL-negative group (99 cases). According to whether patients received low-dose aspirin (LDA) and/or low-molecular-weight heparin (LMWH) therapy, the two groups of patients were further divided into treatment and non-treatment groups and pregnancy outcomes were compared among the groups. Results Among the 167 patients with RSA, the aPL positive rate was 40.72%. The positive rates of lupus anticoagulant (LA), anticardiolipin antibody (aCL), and anti-β2-glycoprotein 1 antibody (anti-β2-GP1) were 24.55%, 4.19%, and 1.80%, respectively. Positivity for any two antibodies at the same time accounted for 7.78%, and positivity for all three antibodies accounted for 2.40%. In both the aPL-positive and aPL-negative groups, the incidence of preeclampsia among pregnant women who received treatment was significantly lower than that in the untreated groups ( P<0.05). Within the aPL-positive group, the full-term delivery rate and newborn birth weight in the treated subgroup were significantly higher than those in the untreated subgroup (P<0.01), while the incidences of fetal growth restriction (FGR) and preterm birth was significantly lower than those in the untreated group (P<0.05). Within the aPL-negative group, the preterm birth rate in the treated subgroup was significantly lower than that in the untreated subgroup, and newborn birth weight was significantly higher than that in the untreated subgroup (P<0.05). Conclusion aPL is closely associated with RSA, and patients with RSA should be actively screened for aPL. Those with positive aPL antibodies should be treated with LDA and/or LMWH. For antibody negative patients, individualized treatment may be considered after full informed consent, with the expectation of achieving satisfactory pregnancy outcomes.
关键词
Key words
[Author(id=1329765375752094108, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=13134101420@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329765375810814366, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, authorId=1329765375752094108, language=EN, stringName=Xin CUI, firstName=Xin, middleName=null, lastName=CUI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329765375856951711, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, authorId=1329765375752094108, language=CN, stringName=崔鑫, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=大连医科大学附属第一医院 产科 ,辽宁 大连 116011, bio={"content":"崔 鑫(2000-),女,硕士研究生。E-mail: 13134101420@163.com
"}, bioImg=null, bioContent=崔 鑫(2000-),女,硕士研究生。E-mail: 13134101420@163.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329765375676596632, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, xref=null, ext=[AuthorCompanyExt(id=1329765375693373849, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, companyId=1329765375676596632, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, China), AuthorCompanyExt(id=1329765375705956762, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, companyId=1329765375676596632, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=大连医科大学附属第一医院 产科 ,辽宁 大连 116011)])]), Author(id=1329765375903089057, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329765375966003619, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, authorId=1329765375903089057, language=EN, stringName=Xin WEN, firstName=Xin, middleName=null, lastName=WEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329765376007946660, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, authorId=1329765375903089057, language=CN, stringName=温欣, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=大连医科大学附属第一医院 产科 ,辽宁 大连 116011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329765375676596632, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, xref=null, ext=[AuthorCompanyExt(id=1329765375693373849, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, companyId=1329765375676596632, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, China), AuthorCompanyExt(id=1329765375705956762, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, companyId=1329765375676596632, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=大连医科大学附属第一医院 产科 ,辽宁 大连 116011)])]), Author(id=1329765376054084006, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329765376112804264, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, authorId=1329765376054084006, language=EN, stringName=Rumeng JI, firstName=Rumeng, middleName=null, lastName=JI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329765376171524521, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, authorId=1329765376054084006, language=CN, stringName=吉如梦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=大连医科大学附属第一医院 产科 ,辽宁 大连 116011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329765375676596632, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, xref=null, ext=[AuthorCompanyExt(id=1329765375693373849, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, companyId=1329765375676596632, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, China), AuthorCompanyExt(id=1329765375705956762, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, companyId=1329765375676596632, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=大连医科大学附属第一医院 产科 ,辽宁 大连 116011)])]), Author(id=1329765376226050475, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wjm210204@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329765376288965038, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, authorId=1329765376226050475, language=EN, stringName=Jingmin WANG, firstName=Jingmin, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329765376339296687, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, authorId=1329765376226050475, language=CN, stringName=王敬民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=大连医科大学附属第一医院 产科 ,辽宁 大连 116011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329765375676596632, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, xref=null, ext=[AuthorCompanyExt(id=1329765375693373849, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, companyId=1329765375676596632, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, China), AuthorCompanyExt(id=1329765375705956762, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765373822714259, companyId=1329765375676596632, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=大连医科大学附属第一医院 产科 ,辽宁 大连 116011)])])]
崔鑫,温欣,吉如梦,王敬民.
复发性流产患者抗磷脂抗体分布特征及妊娠结局分析[J].
大连医科大学学报, 2026, 48(3): 225-230 DOI:10.11724/jdmu.2026.03.05
| [1] |
中华医学会妇产科学分会产科学组. 复发性流产诊治专家共识 (2022)[J]. 中华妇产科杂志, 2022, 57(9): 653-666. DOI: 10.3760/cma.j.cn112141-20220421-00259.
|
| [2] |
Coomarasamy A, Dhillon-Smith RK, Papadopoulou A, et al. Recurrent miscarriage: evidence to accelerate action[J]. Lancet, 2021, 397(10285): 1675-1682. DOI: 10.1016/S0140-6736(21)00681-4.
|
| [3] |
Al Jameil N, Tyagi P, Al Shenefy A. Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death[J]. Int J Clin Exp Pathol, 2015, 8(3): 3204-3209.
|
| [4] |
Bansal AS, Bajardeen B, Shehata H, et al. Recurrent miscarriage and autoimmunity[J]. Expert Rev Clin Immunol, 2011, 7(1): 37-44. DOI: 10.1586/eci.10.84.
|
| [5] |
Swadźba J, Iwaniec T, Szczeklik A, et al. Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases[J]. J Thromb Haemost, 2007, 5(9): 1883-1889. DOI: 10.1111/j.1538-7836.2007.02669.x.
|
| [6] |
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006, 4(2): 295-306. DOI: 10.1111/j.1538-7836.2006.01753.x.
|
| [7] |
National Health, Family Planning Commission of the People's Republic of China. Health Industry Standard: Criteria of Weight for Adults[M]. Beijing: Chinese Standards Press, 2013: 15.
|
| [8] |
中华医学会妇产科学分会产科学组. 复发性流产诊治的专家共识[J]. 中华妇产科杂志, 2016, 51(1): 3-9. DOI: 10.3760/cma.j.issn.0529-567x.2016.01.002.
|
| [9] |
Coomarasamy A, Devall AJ, Brosens JJ, et al. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence[J]. Am J Obstet Gynecol, 2020, 223(2): 167-176. DOI: 10.1016/j.ajog.2019.12.006.
|
| [10] |
Rpl TEGGO, Bender Atik R, Christiansen OB, et al. ESHRE guideline: recurrent pregnancy loss[J]. Hum Reprod Open, 2018, 2018(2): hoy004. DOI: 10.1093/hropen/hoy004.
|
| [11] |
Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults[J]. Ann Rheum Dis, 2019, 78(10): 1296-1304. DOI: 10.1136/annrheumdis-2019-215213.
|
| [12] |
上海市医学会妊娠免疫专科分会, 全国卫生产业企业管理协会生殖免疫专业委员会, 复发性流产病因分级筛查临床实践中国专家共识编写组, 等. 复发性流产病因分级筛查临床实践中国专家共识 (2025 年版)[J]. 中国实用妇科与产科杂志, 2025, 41(11): 1111-1123. DOI: 10.19538/j.fk2025110112.
|
| [13] |
Chen YX, Xu WC, Huang S, et al. Analysis of pregnancy outcomes in patients exhibiting recurrent miscarriage with concurrent low-titer antiphospholipid antibodies[J]. American J Rep Immunol, 2024, 92(5): e13940. DOI: 10.1111/aji.13940.
|
| [14] |
徐敏倩, 罗晓红. 抗磷脂抗体综合征相关性复发性流产的研究进展[J]. 中国医药科学, 2021, 11(10): 45-48. DOI: 10.3969/j.issn.2095-0616.2021.10.010.
|
| [15] |
董雪梅, 张翀, 马宁霞, 等. 复发性流产患者抗磷脂抗体分布分析[J]. 血栓与止血学, 2022, 28(5): 1152-1157. DOI: 10.3969/j.issn.1009-6213.2022.05.004.
|
| [16] |
Shaikhomar OA, Ali ST. A comparative analysis of anticardiolipin, anti-Β2-glycoprotein-1, and lupus anticoagulants in Saudi women with recurrent spontaneous abortions[J]. J Pers Med, 2023, 13(1): 2. DOI: 10.3390/jpm13010002.
|
| [17] |
Regan L, Rai R, Saravelos S, et al. Recurrent MiscarriageGreen-top guideline No. 17[J]. BJOG, 2023, 130(12): e9-e39. DOI: 10.1111/1471-0528.17515.
|
| [18] |
Lockshin MD, Kim M, Laskin CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies[J]. Arthritis Rheum, 2012, 64(7): 2311-2318. DOI: 10.1002/art.34402.
|
| [19] |
Guo H, Zhang YC, Li AW, et al. Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients[J]. Clin Exp Med, 2019, 19(3): 339-345. DOI: 10.1007/s10238-019-00555-w.
|
| [20] |
Gebhart J, Posch F, Koder S, et al. High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant[J]. Blood Advances, 2019, 3(5): 769-776. DOI: 10.1182/blood-advances.2018026948.
|
| [21] |
Urbanus RT, Derksen RH, de Groot PG. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome[J]. Blood Rev, 2008, 22(2): 93-105. DOI: 10.1016/j.blre.2007.09.001.
|
| [22] |
中华医学会围产医学分会. 产科抗磷脂综合征诊断与处理专家共识[J]. 中华围产医学杂志, 2020, 23(8): 517-522. DOI: 10.3760/cma.j.cn113903-20200402-00299.
|
| [23] |
施君, 赵爱民. 妊娠合并抗磷脂综合征的诊治[J]. 中国实用妇科与产科杂志, 2016, 32(10): 948-952. DOI: 10.7504/fk2016090108.
|
| [24] |
de Jesús GR, Benson AE, Chighizola CB, et al. 16th international congress on antiphospholipid antibodies task force report on obstetric antiphospholipid syndrome[J]. Lupus, 2020, 29(12): 1601-1615. DOI: 10.1177/0961203320954520.
|
| [25] |
低分子肝素防治自然流产中国专家共识编写组. 低分子肝素防治自然流产中国专家共识[J]. 中华生殖与避孕杂志, 2018, 38(9): 701-708. DOI: 10.3760/cma.j.issn.2096-2916.2018.09.001.
|
| [26] |
Cohen H, Cuadrado MJ, Erkan D, et al. 16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends[J]. Lupus, 2020, 29(12): 1571-1593. DOI: 10.1177/0961203320950461.
|
| [27] |
Roberge S, Nicolaides K, Demers S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2017, 216(2): 110-120. e6. DOI: 10.1016/j.ajog.2016.09.076.
|
| [28] |
Rasmark Roepke E, Hellgren M, Hjertberg R, et al. Treatment efficacy for idiopathic recurrent pregnancy loss-a systematic review and meta-analyses[J]. Acta Obstet Gynecol Scand, 2018, 97(8): 921-941. DOI: 10.1111/aogs.13352.
|
| [29] |
Wijeyaratne CN, Galappaththi S, Palipane E, et al. Pregnancy outcomes of antiphospholipid syndrome: in a low resource South Asian setting[J]. Obstet Med, 2016, 9(2): 83-89. DOI: 10.1177/1753495X16629300.
|
| [30] |
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, et al. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases[J]. Autoimmun Rev, 2019, 18(4): 406-414. DOI: 10.1016/j.autrev.2018.12.006.
|
| [31] |
da Silva Santos T, Ieque AL, de Carvalho HC, et al. Antiphospholipid syndrome and recurrent miscarriage: a systematic review and meta-analysis[J]. J Reprod Immunol, 2017, 123: 78-87. DOI: 10.1016/j.jri.2017.09.007.
|
| [32] |
陈玥, 王敬民, 李相君, 等. 小剂量阿司匹林联合低分子肝素治疗时长对产科抗磷脂综合征妊娠结局的影响[J]. 中国实用妇科与产科杂志, 2022, 38(7): 739-742. DOI: 10.19538/j.fk2022070115.
|
| [33] |
Karadağ C, Akar B, Gönenç G, et al. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation[J]. J Matern Fetal Neonatal Med, 2020, 33(11): 1934-1939. DOI: 10.1080/14767058.2019.1671348.
|
| [34] |
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, et al. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry[J]. Rheumatology (Oxford), 2020, 59(6): 1306-1314. DOI: 10.1093/rheumatology/kez419.
|
| [35] |
Hamulyák EN, Scheres LJ, Marijnen MC, et al. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss[J]. Cochrane Database Syst Rev, 2020, 5(5): CD012852. DOI: 10.1002/14651858.CD012852.pub2.
|
| [36] |
李聪聪, 赵爱民. 不明原因复发性流产的免疫指标筛查及诊治策略[J]. 实用妇产科杂志, 2021, 37(8): 567-570.
|
| [37] |
高睿, 秦朗, 陈晗笑. 阿司匹林联合低分子肝素治疗原因不明复发性流产的临床疗效: 系统评价与 Meta 分析[J]. 中国计划生育和妇产科, 2021, 13(5): 74-80. DOI: 10.3969/j.issn.1674-4020.2021.05.19.
|
| [38] |
Saccone G, Berghella V, Maruotti GM, et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study[J]. Am J Obstet Gynecol, 2017, 216(5): 525. e1-525. e12. DOI: 10.1016/j.ajog.2017.01.026.
|
| [39] |
自然流产诊治中国专家共识编写组. 自然流产诊治中国专家共识 (2020 年版)[J]. 中国实用妇科与产科杂志, 2020, 36(11): 1082-1090. DOI: 10.19538/j.fk2020110113.
|
| [40] |
Kuroda K, Ikemoto Y, Horikawa T, et al. Novel approaches to the management of recurrent pregnancy loss: the OPTIMUM (OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu) treatment strategy[J]. Reprod Medicine & Biology, 2021, 20(4): 524-536. DOI: 10.1002/rmb2.12412.
|